0000899243-20-025360.txt : 20200916 0000899243-20-025360.hdr.sgml : 20200916 20200916180951 ACCESSION NUMBER: 0000899243-20-025360 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200914 FILED AS OF DATE: 20200916 DATE AS OF CHANGE: 20200916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Leggett Thomas CENTRAL INDEX KEY: 0001774690 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39200 FILM NUMBER: 201179644 MAIL ADDRESS: STREET 1: C/O AXCELLA HEALTH INC. STREET 2: 840 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Black Diamond Therapeutics, Inc. CENTRAL INDEX KEY: 0001701541 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-417-5868 MAIL ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Aset Therapeutics, Inc. DATE OF NAME CHANGE: 20170321 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-09-14 0 0001701541 Black Diamond Therapeutics, Inc. BDTX 0001774690 Leggett Thomas C/O BLACK DIAMOND THERAPEUTICS, INC. 139 MAIN STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Financial Officer Common Stock 2020-09-14 4 M 0 3000 10.86 A 3000 D Common Stock 2020-09-14 4 S 0 3000 31.00 D 0 D Stock Option (Right to Buy) 10.86 2020-09-14 4 M 0 3000 0.00 D 2029-09-08 Common Stock 3000 230171 D Shares sold pursuant to a pre-established 10b5-1 trading plan effective as of June 5, 2020. 25% of the shares subject to this option vested and became exercisable on September 5, 2020, with the remainder vesting in 36 equal monthly installments thereafter. /s/ Brent Hatzis-Schoch, as Attorney-in-Fact 2020-09-16